%0 Journal Article
%T Effect of Cetuximab and EGFR Small Interfering RNA Combination Treatment in NSCLC Cell Lines with Wild Type EGFR and Use of KRAS as a Possible Biomarker for Treatment Responsiveness
%A Akira Yamasaki
%A Hiroki Chikumi
%A Kensaku Okada
%A Kosuke Yamaguchi
%A Masaki Nakamoto
%A Miki Takata
%A Miyako Takata
%A Naomi Miyake
%A Tsuyoshi Kitaura
%J Archive of "Yonago Acta Medica".
%D 2019
%R 10.33160/yam.2019.03.012
%X pj.ca.u-irottot.dem@imukih
%K cetuximab
%K EGFR siRNA
%K KRAS
%K non-small cell lung cancer
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437414/